Catalyst Biosciences Inc. (CBIO)

10.36 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 10.36

Price Open 10.14

Volume: 160,708

Avg Volume: 646,333

Market Cap: 123.73M

P/E Ratio -3.05

52 Wk Range 3.11-37



CBIO Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
11.55M
1.01M
1.16
8.77%

2018-07-13
11.54M
939,312
0.80
8.14%

2018-06-29
11.54M
916,353
0.88
7.94%

2018-06-15
11.54M
258,879
1.18
2.24%




CBIO Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-10
Q1 2018
N/A
-1.30 (1)
0.00
0.00

2018-05-03
Q1 2018
N/A
-1.30 (1)
-0.56
0.74

2018-03-14
Q4 2017
N/A
-1.79 (1)
0.00
0.00

2018-03-01
Q4 2017
N/A
-1.41 (1)
-0.96
0.45

News

Catalyst Bio's MarzAA continues to shows positive action in hemophilia study; shares up 4% premarket (2018-08-15 08:43 SeekingAlpha)

Catalyst Biosciences (NASDAQ: CBIO ) is up 4% premarket on light volume on the heels of its announcement of updated preliminary data from its open-label Phase 2/3 clinical trial evaluating subcutaneously administered prophylactic Factor VIIa variant marzeptacog alfa (activated)…

 


Statistics

Shares Outstanding: 11.94M

Top 15 Institution Percent: 82.10

Price To Sales: 188.44

Price To Book: 0.88

Revenue: 318000

Gross Profit: N/A

Cash: 27.45M

Debt: N/A

Return On Assets: -25.75

Return On Equity: -27.58

Profit Margin: N/A

Price History

Beta: 1.90

50-day Moving Avg: 12.97

200-day Moving Avg: 18.42

YTD Change: -27.91

5-day Change: 2.98

1-month Change: -15.15

3-month Change: -63.65

6-month Change: -66.67

1-year Change: N/A

Revenue Per Share: 0.00

Revenue Per Employee: 24462.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Catalyst Biosciences Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.catalystbiosciences.com

Catalyst Biosciences Inc focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options.